From a phase 3 durability readout for a first-in-class TKI to a new interchangeable ranibizumab biosimilar and a deep dive into geographic atrophy management, June brought a wide-ranging mix of regulatory, clinical, and practice-pattern news for retina specialists

The Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting was held here May 3–7 with a focus on “Achieving Precision Ophthalmology Through Innovative Vision Research.”

At ARVO 2026, Michael Ip, MD, presented findings from a large-scale analysis of OCT biomarkers in patients with diabetic macular edema (DME), leveraging the robust DRCR Retina Network Protocol T dataset.

SriniVas Sadda, MD, FARVO, discusses his paper on subretinal hyperreflective material (SHRM), its relevance to vision, and findings from the TENAYA and LUCERNE studies.

Srinivas Sadda, MD, FARVO, immediate past president of ARVO, discusses the impact the organization has had on his career and how he wants to help the next generation.

At this year’s ARVO meeting in Denver, Colorado, Giulia Corradetti spoke on how baseline OCT biomarkers can predict anatomic response in neovascular age-related macular degeneration when treated with faricimab.

Join us for a special presentation with retina specialist SriniVas Sadda, MD, FARVO, Director of Artificial Intelligence & Imaging Research at Doheny Eye Institute and Professor of Ophthalmology at the David Geffen School of Medicine at UCLA.

The Luminaires, a dedicated support group for the Doheny Eye Institute, hosted their “Timeless Elegance” annual benefit at the Langham Huntington Hotel in Pasadena on March 13.

Your bedtime routine could be impacting your eyes. Many of our daily routines have a direct impact on our overall health, and our eyes are no exception.

An aging population is driving a steady rise in reported cases of age-related macular degeneration (AMD), and with AMD and Low Vision Awareness Month underway this month, education and advocacy are top of mind for eyecare professionals (ECPs) who treat patients with this condition.

By: Brian A. Francis, MD, MS Brian A. Francis, MD, discusses emerging...

By: Sumer Bowles Executive Health & Wellness: Advancing Care Across...

Discover how RGB technology enhances eye disease diagnosis, improving accuracy and efficiency in clinical practice with advanced imaging techniques.

Deborah A. Ferrington, PhD, highlights how breakthroughs in imaging, AI, and stem cell research are reshaping ophthalmology.

SriniVas R. Sadda, MD, FARVO, recalls a residency case that highlights the transformative impact of OCT and OCT angiography.

Have a headache and there is pain from around your eyes? Is it an eye problem? “In some cases, the brain or your mind can be not very good at differentiating what pain is coming from the eyeball itself, what is coming from the structures round about the eyeball — what we call the orbit, the eye socket — or what is actually truly coming from other parts of the head, and it feels to the patient as if it’s coming from the eyes,” explains Michael Gilhooley, M.D., Ph.D., a neuro-ophthalmologist at Doheny Eye Institute in Pasadena, California.

Pain from around or behind the eyes is a feature of many headaches. But that doesn’t mean that there aren’t painful eye conditions that cause headaches, explains Michael Gilhooley, M.D., Ph.D., a neuro-ophthalmologist at the Doheny Eye Institute in Pasadena, California.

Alfredo A. Sadun, M.D., Ph.D., discusses two applications of AI in ophthalmology where AI far exceeds what a human ophthalmologist can do.